Brexit Effect on Biosimilar


The negative tendency of biosimilars Brexit impact. The hindrance towards the value cutting approach taken by the NHS may be a major setback towards approval and launch of biosimilars in market. With Britain being among foremost clinical preliminary focuses is claimed to ascertain a diminishing within the eagerness of the manufacturers and specialists to try to to any longer preliminaries in Britain. Additionally, Brexit will cause the first rationale of British Biosimilars Association (BBA) to fall back-which went for expanding the use of Biosimilars.


  • No Tariffs or Quotas
  • Life Sciences Investment
  • The

Related Conference of Brexit Effect on Biosimilar

April 03-04, 2023

16th European Biosimilars Congress

Barcelona, Spain
April 25-26, 2023

4th Annual Congress on Antibiotics and Bacterial Infections

Amsterdam, Netherlands
May 07-08, 2023

Advanced-Materials 2023

Valencia, Spain
July 06-07, 2023

5th World Congress on Drug Discovery and Drug Design

Vancouver, Canada
July 25-26, 2023

36th World Congress on Pharmacology

Amsterdam, Netherlands
August 11-12, 2023

38th World Congress on Pharmacology and Therapeutics

Singapore City, Singapore
September 06-07, 2023

16th World Drug Delivery Summit

London, UK
September 14-15, 2023

10th international conference on Physiotherapy

Bangkok, Thailand
September 27-28, 2023

3rd World Congress on Rare Diseases & Orphan Drugs

Amsterdam, Netherlands
September 27-28, 2023

8th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
October 09-10, 2023

20th International Conference on Pharmaceutical Chemistry

Barcelona, Spain
October 12-13, 2023

26th World Congress on Nursing, Pharmacology and Healthcare

Budapest, Hungary
November 09-10, 2023

11th International Conference on Clinical Trials

London, UK
November 10-11, 2023

3rd World Biosimilars & Biologics Congress

Berlin, Germany
November 27-28, 2023

19th World Congress on Drug Formulation & Drug Delivery

Bangkok, Thailand
December 05-06, 2023

2nd World Congress on Precision and Personalized Medicine

Zurich, Switzerland

Brexit Effect on Biosimilar Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in